/Agilent%20Technologies%20Inc_%20HQ%20sign-by%20hapabapa%20via%20iStock.jpg)
With a market cap of $42.3 billion, Agilent Technologies, Inc. (A) delivers application-focused solutions for the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab, offering a broad portfolio of instruments, consumables, software, and laboratory services.
Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Agilent Technologies fits this criterion perfectly. Agilent distributes its products primarily through a direct sales model, complemented by distributors, resellers, representatives, and e-commerce channels.